Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SunAmerica Series Trust is a registered open-end management investment company organized as a Massachusetts business trust and used as a fund platform for insurance-dedicated investment portfolios. Its portfolios are offered primarily through separate accounts of affiliated and unaffiliated life insurance companies and, for some portfolios, to other mutual funds. The trust is part of the SunAmerica/Corebridge variable insurance investment ecosystem rather than a biotechnology, pharmaceutical, or healthcare operating company. It does not develop therapeutics or medical products; instead, it provides investment exposure across multiple asset management strategies through numerous separate portfolios. For a biotech analyst, this entity is best understood as a financial services fund vehicle, not a life sciences company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SunAmerica Series Trust.